What's happening
This bill adds drug shortages to the list of events that trigger price gouging protections for medicine in New York.
Why it matters
Expands consumer protection to drug shortages. By explicitly adding "drug shortage" as a trigger for price gouging protections, the bill ensures that New Yorkers are shielded from sudden and extreme price increases for medicines when supply is low—regardless of whether a formal emergency is declared.
Aligns state action with federal reporting. The bill defines a "drug shortage" as any medication or medical product publicly reported as such by the U.S. Food and Drug Administration. This linkage to FDA reporting provides a clear, objective standard for when protections kick in, making enforcement more predictable and less subject to local discretion.
Targets the entire supply chain. The amendment reaffirms that price gouging prohibitions apply not only to retailers, but also to manufacturers, suppliers, wholesalers, and distributors. This means all levels of the pharmaceutical supply chain are subject to scrutiny if they raise prices excessively during a shortage.
Addresses both access and affordability. By broadening the scope of what counts as an "abnormal disruption," the bill aims to maintain both the availability and affordability of essential medicines during periods of high demand or low supply, potentially preventing exploitation of vulnerable consumers during health crises.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Who cares
Drug manufacturers and wholesalers
The bill would explicitly add drug shortages to the market disruptions covered by the ban on unconscionably excessive prices throughout the distribution chain.
Pharmacies and medical-product retailers
Retail sellers would face price-gouging restrictions during covered shortages when the products were located in New York before sale.
Patients who need medicines or medical products in shortage
The bill would extend explicit price-gouging protections to shortages of human-use drugs or medical products publicly reported by the U.S. Food and Drug Administration.
Headline styles
Stop Medicine Price Gouging
Plain English, a few words. Used as the page title.
Sponsors
History
- Signed chap.725
- Delivered to governor
- Returned to senate
- Passed assembly
- Ordered to third reading cal.175
- Substituted for A5653B
- Returned to assembly
- Repassed senate
- Amended on third reading 608c
- Amended on third reading 608b
- Vote reconsidered - restored to third reading
- Returned to senate
Show 9 earlier actions
- Recalled from assembly
- Referred to consumer affairs and protection
- Delivered to assembly
- Passed senateVote 62–0
- Ordered to third reading cal.77
- Reported and committed to rules
- Print number 608a
- Amend and recommit to consumer protection
- Referred to consumer protection
Companion bill
The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.
Stop Drug Price Gouging
Assembly Floor Calendar · Sponsor Karines Reyes
Full text
2 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
608--C Cal. No. 77
2023-2024 Regular Sessions
IN SENATE
January 5, 2023
Introduced by Sens. SALAZAR, BRISPORT, GIANARIS, HELMING, JACKSON, KRUEGER, LANZA, LIU, SANDERS, SERRANO -- read twice and ordered printed, and when printed to be committed to the Committee on Consumer Protection -- committee discharged, bill amended, ordered… Show allHide
Introduced by Sens. SALAZAR, BRISPORT, GIANARIS, HELMING, JACKSON, KRUEGER, LANZA, LIU, SANDERS, SERRANO -- read twice and ordered printed, and when printed to be committed to the Committee on Consumer Protection -- committee discharged, bill amended, ordered reprinted as amended and recommitted to said committee -- reported favorably from said committee and committed to the Committee on Rules -- reported favorably from said committee, ordered to a third reading, passed by Senate and delivered to the Assembly, recalled, vote reconsidered, restored to third reading, amended and ordered reprinted, retaining its place in the order of third reading -- again amended and ordered reprinted, retaining its place in the order of third reading
AN ACT to amend the general business law, in relation to the price gouging of medicine
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. Subdivision 2 of section 396-r of the general business law, as amended by chapter 90 of the laws of 2020, is amended to read as follows:
2. (a) During any abnormal disruption of the market for goods and services vital and necessary for the health, safety and welfare of consumers or the general public, no party within the chain of distribution of such goods or services or both shall sell or offer to sell any such goods or services or both for an amount which represents an unconscionably excessive price.
(b) For purposes of this section, the phrase "abnormal disruption of the market" shall mean any change in the market, whether actual or imminently threatened, resulting from stress of weather, convulsion of nature, failure or shortage of electric power or other source of energy, strike, civil disorder, war, military action, national or local emergency, drug shortage, or other cause of an abnormal disruption of the
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD03763-10-3
market which results in the declaration of a state of emergency by the governor.
(c) For purposes of this section, the term "drug shortage" shall mean, with respect to any drug or medical product intended for human use, that such drug or medical product is publicly reported as being subject to a shortage by the U.S. Food and Drug Administration.
(d) For the purposes of this section, the term "goods and services" shall include [(a)] (i) consumer goods and services used, bought or rendered primarily for personal, family or household purposes, [(b)] (ii) essential medical supplies and services used for the care, cure, mitigation, treatment or prevention of any illness or disease, and [(c)] (iii) any other essential goods and services used to promote the health or welfare of the public.
(e) This prohibition shall apply to all parties within the chain of distribution, including any manufacturer, supplier, wholesaler, distributor or retail seller of goods or services or both sold by one party to another when the product sold was located in the state prior to the sale. [Goods] For the purposes of this subdivision, the term "goods and services" shall also include any repairs made by any party within the chain of distribution of goods on an emergency basis as a result of such abnormal disruption of the market.
§ 2. This act shall take effect immediately.
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Sponsor's memo
Title of bill
An act to amend the general business law, in relation to the price goug- ing of medicine
Purpose or general idea of the bill
This legislation adds medicine to the list of goods and services that can be classified as possibly being subject to price gouging.
Summary of specific provisions
Section 1: Amends subdivision 2 of section 396-r of the general business law to add the phrase "drug shortage" to the definition of "abnormal disruption of the market" and to further define the phrase "drug short- age" to mean the issuance of a notice by the U.S. Food and Drug Adminis- tration declaring a drug shortage.
Section 2: Establishes the effective date.
Difference from the original version of the bill
The B print clarified the federal laws and agencies referred to under the statute. The C print corrects a minor drafting error.
Justification
Price gouging of medicine is a well-documented and significant issue that interferes with the ability of many people to access necessary medication and contributes to soaring profits of some pharmaceutical corporations. Price gouging of medication has a racially disparate impact, with people of color and communities of color, as well as less affluent communities in general, disproportionately impacted.
This bill originally was developed in the wake of workshops on improving health care access for Latinos by the NYS Assembly Puerto Rican Hispanic Task Force (PRHTF) during its annual legislative' conference in 2011.
Although this issue has gained prominent media attention, the problem remains.
This bill would provide the New York State, through the Office of the Attorney General with additional tools and authority to respond to price gouging of medication and to, thereby, protect public health and ease disparities in health-care access, treatment, and outcomes.
Social justice impact
This legislation would contribute to the right of New Yorkers to afford- able and exceptional health care. This legislation would put the afford- able treatment of New Yorkers over the profits of secondary market companies.
Prior legislative history
SENATE: 2019: S3654 (Salazar) Referred to Consumer Protection, Committed to Rules, Passed Senate
2020: Referred to Consumer Protection, Passed Assembly
2021:S3081B (Salazar) Referred to Consumer Protection, Committed to Rules, Passed Senate
2022: Referred to Consumer Protection, Passed Senate, Passed Assembly, Vetoed by Governor, Veto Memo 162.
Fiscal implications for state and local government
None
Effective date
This bill will take effect immediately.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.